Murata M, Fukuyama M, Satoh K, Fujimura Y, Yoshioka A, Takahashi H, Handa M, Kawai Y, Watanabe K, Ikeda Y
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
J Clin Invest. 1993 Sep;92(3):1555-8. doi: 10.1172/JCI116735.
Platelets exposed to shear stress aggregate in the absence of exogenously added agonists, utilizing distinct platelet membrane receptors and ligands depending upon the level of shear stress applied. Using a modified cone and plate type viscometer, we previously demonstrated that, under low shear stress (18 dyn/cm2), aggregation is mediated by platelet membrane glycoprotein (GP) IIb-IIIa and fibrinogen, whereas aggregation induced by high shear stress (108 dyn/cm2) requires the binding of von Willebrand factor (vWF) to both GPIb-IX and GPIIb-IIIa (Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, I. Itagaki, et al. 1991. J. Clin. Invest. 87:1234-1240). Here we report that vWF-dependent aggregation occurs under low shear stress in citrated platelet-rich plasma (PRP) from two types of congenital bleeding disorders, platelet-type von Willebrand disease (vWD) and type IIB vWD, in both of which ristocetin-induced aggregation is known to be heightened. Aggregation induced by low shear stress was enhanced in both types of disorders compared to normal controls, and the enhancement was completely abolished by anti-vWF monoclonal antibody NMC-4, which blocks the GPIb-binding site on vWF. Under high shear stress, the extent of maximal aggregation was not different between controls and the patient groups although maximal aggregation was reached much more quickly in the latter. When citrated PRP was exposed to a gradient of shear stress (6 to 108 dyn/cm2 over a 5-min period), vWF-dependent aggregation, as judged from the inhibitory effect of NMC-4, first occurred at 14 dyn/cm2 in platelet-type vWD and at 10-12 dyn/cm2 in type IIB vWD, as compared with more than 81 +/- 20.1 dyn/cm2 in control platelets. These results suggest that an abnormality in either vWF or GPIb-IX triggers the aggregation-inducing interaction of the two molecules under low shear stress, which might explain the intravascular platelet clumping, that presumably underlies the thrombocytopenia observed in these bleeding disorders.
暴露于剪切应力下的血小板在没有外源性添加激动剂的情况下会发生聚集,这取决于所施加的剪切应力水平,利用不同的血小板膜受体和配体。我们之前使用改良的锥板型粘度计证明,在低剪切应力(18达因/平方厘米)下,聚集由血小板膜糖蛋白(GP)IIb-IIIa和纤维蛋白原介导,而高剪切应力(108达因/平方厘米)诱导的聚集需要血管性血友病因子(vWF)与GPIb-IX和GPIIb-IIIa两者结合(池田洋、半田真、川野健、镰田哲、村田正、荒木洋、安保浩、河合洋、渡边健、板垣一,等人,1991年,《临床研究杂志》87:1234 - 1240)。在此我们报告,在两种先天性出血性疾病——血小板型血管性血友病(vWD)和IIB型vWD的枸橼酸化富血小板血浆(PRP)中,低剪切应力下会发生vWF依赖性聚集,在这两种疾病中,已知瑞斯托霉素诱导的聚集会增强。与正常对照相比,两种疾病中低剪切应力诱导的聚集均增强,并且这种增强被抗vWF单克隆抗体NMC - 4完全消除,该抗体可阻断vWF上的GPIb结合位点。在高剪切应力下,尽管患者组达到最大聚集的速度要快得多,但对照组和患者组之间最大聚集程度并无差异。当枸橼酸化PRP暴露于剪切应力梯度(5分钟内从6到108达因/平方厘米)时,根据NMC - 4的抑制作用判断,vWF依赖性聚集在血小板型vWD中首先出现在14达因/平方厘米,在IIB型vWD中出现在10 - 12达因/平方厘米,而对照血小板中则超过81±20.1达因/平方厘米。这些结果表明,vWF或GPIb - IX的异常会在低剪切应力下触发这两种分子的聚集诱导相互作用,这可能解释了血管内血小板聚集,而这大概是这些出血性疾病中观察到的血小板减少的基础。